American Money Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.9M Sell
43,177
-571
-1% -$123K 1.55% 22
2026
Q1
$9.51M Sell
43,748
-241
-0.5% -$53.5K 1.51% 22
2025
Q4
$10.1M Buy
43,989
+2,778
+7% +$633K 1.58% 20
2025
Q3
$9.54M Buy
41,211
+340
+0.8% +$69.2K 1.59% 23
2025
Q2
$7.59M Sell
40,871
-24
-0.1% -$4.46K 1.34% 25
2025
Q1
$8.57M Sell
40,895
-128
-0.3% -$24.9K 1.63% 19
2024
Q4
$7.29M Buy
41,023
+284
+0.7% +$52.2K 1.42% 22
2024
Q3
$8.05M Sell
40,739
-387
-0.9% -$72.2K 1.61% 21
2024
Q2
$7.05M Sell
41,126
-116
-0.3% -$19.2K 1.51% 22
2024
Q1
$7.51M Sell
41,242
-214
-0.5% -$36.9K 1.57% 19
2023
Q4
$6.42M Buy
41,456
+553
+1% +$80.6K 1.45% 22
2023
Q3
$6.1M Buy
40,903
+2,072
+5% +$304K 1.56% 21
2023
Q2
$5.23M Sell
38,831
-34
-0.1% -$4.99K 1.3% 27
2023
Q1
$6.19M Sell
38,865
-904
-2% -$138K 1.65% 15
2022
Q4
$6.43M Buy
39,769
+80
+0.2% +$12.3K 1.83% 12
2022
Q3
$5.33M Buy
39,689
+700
+2% +$100K 1.62% 16
2022
Q2
$5.97M Sell
38,989
-7,720
-17% -$1.18M 1.74% 14
2022
Q1
$7.57M Sell
46,709
-341
-0.7% -$49.5K 2.01% 6
2021
Q4
$6.37M Buy
47,050
+89
+0.2% +$10.5K 1.65% 17
2021
Q3
$5.07M Buy
46,961
+4,253
+10% +$486K 1.43% 23
2021
Q2
$4.81M Buy
42,708
+8
+0% +$901 1.63% 24
2021
Q1
$4.62M Sell
42,700
-416
-1% -$44.5K 1.72% 22
2020
Q4
$4.62M Buy
43,116
+475
+1% +$45.6K 1.81% 20
2020
Q3
$3.73M Buy
42,641
+1,058
+3% +$99.6K 1.69% 27
2020
Q2
$4.07M Sell
41,583
-352
-0.8% -$31K 1.9% 16
2020
Q1
$3.19M Buy
41,935
+406
+1% +$34.6K 1.79% 21
2019
Q4
$3.68M Sell
41,529
-234
-0.6% -$19.4K 1.72% 24
2019
Q3
$3.16M Sell
41,763
-2,546
-6% -$175K 1.69% 27
2019
Q2
$3.22M Buy
44,309
+1,832
+4% +$144K 1.72% 26
2019
Q1
$3.42M Sell
42,477
-542
-1% -$44.3K 1.9% 21
2018
Q4
$3.97M Sell
43,019
-179
-0.4% -$15.7K 2.5% 10
2018
Q3
$4.09M Buy
43,198
+2,019
+5% +$191K 2.34% 12
2018
Q2
$3.81M Sell
41,179
-607
-1% -$59.3K 2.31% 13
2018
Q1
$3.96M Sell
41,786
-2,577
-6% -$283K 2.47% 10
2017
Q4
$4.29M Sell
44,363
-503
-1% -$47.4K 2.6% 9
2017
Q3
$3.99M Sell
44,866
-291
-0.6% -$22.2K 2.65% 7
2017
Q2
$3.27M Sell
45,157
-413
-0.9% -$27.8K 2.33% 10
2017
Q1
$2.97M Buy
45,570
+3,217
+8% +$202K 2.19% 14
2016
Q4
$2.65M Sell
42,353
-911
-2% -$55.6K 2.13% 15
2016
Q3
$2.73M Buy
43,264
+535
+1% +$34.6K 2.18% 14
2016
Q2
$2.65M Sell
42,729
-874
-2% -$53.3K 2.19% 15
2016
Q1
$2.49M Buy
43,603
+6,035
+16% +$336K 2.06% 18
2015
Q4
$2.23M Buy
37,568
+2,615
+7% +$151K 1.91% 22
2015
Q3
$1.9M Sell
34,953
-3,139
-8% -$204K 1.8% 29
2015
Q2
$2.56M Sell
38,092
-499
-1% -$32.6K 2.16% 12
2015
Q1
$2.26M Buy
38,591
+8,127
+27% +$491K 1.97% 14
2014
Q4
$1.99M Sell
30,464
-6,254
-17% -$394K 1.72% 22
2014
Q3
$2.12M Sell
36,718
-980
-3% -$54.4K 1.8% 17
2014
Q2
$2.13M Buy
37,698
+70
+0.2% +$3.67K 1.74% 16
2014
Q1
$1.93M Buy
37,628
+4,673
+14% +$236K 1.64% 19
2013
Q4
$1.74M Buy
+32,955
New +$1.62M 1.5% 29

Other funds holding ABBV

American Money Management's ABBV Position: Q2 2026 in Review

American Money Management reduced its AbbVie (ABBV) stake by 1.3% in Q2 2026, selling an estimated $123K and leaving 43,177 shares worth $10.9M. The position accounts for 1.55% of the portfolio, ranked #22.

American Money Management first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • American Money Management held 43,177 shares of AbbVie worth $10.9M as of Q2 2026.
  • American Money Management sold 571 AbbVie shares in Q2 2026, an estimated $123K.
  • AbbVie made up 1.55% of American Money Management's portfolio in Q2 2026, its #22 holding.
  • American Money Management first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on American Money Management's 13F filing for Q2 2026, filed 13 Aug 2026.